OR WAIT null SECS
© 2022 MJH Life Sciences and Formulary Watch. All rights reserved.
© 2022 MJH Life Sciences™ and Formulary Watch. All rights reserved.
CAPSTONE HEALTH SERVICES FOUNDATION PC
850 5TH AVE E
December 05, 2022
If approved, clotrimazole would be the first topical drug indicated to treat otomycosis, an ear infection caused by a fungus.
December 01, 2022
Lecanemab is an investigational anti-amyloid beta antibody to treat mild cognitive impairment due to Alzheimer’s disease. It is currently under review by the FDA and a decision is expected by Jan. 6.
November 23, 2022
Adderall pills containing methamphetamine and oxycodone pills containing fentanyl have been among the fake pills the DEA and investigators have confiscated.
November 21, 2022
The FDA has issued a final guidance for beta-lactam oral antibiotic suspension products, including amoxicillin.
November 16, 2022
The agency is encouraging sponsors to submit applications for low-dose, nonprescription naloxone products.
November 15, 2022
After review of phase 3 data, GSK will limit the use of Zejula in the second line to those with inherited BRCA mutations.